Schumacher A
Medizinische Klinik, Universität Münster.
Med Klin (Munich). 1994 Aug 15;89(8):410-5.
In oncology, quality of life has become an essential criterion for evaluating the effects of therapy in clinical trials. So far, in adult patients suffering from acute leukemia assessment of quality of life has not been considered possibly due to poor prognosis and the acute course of the disease. Advances in chemotherapy significantly prolong survival of patients with acute myeloid leukemia and may cure a subset of patients. Therefore, the assessment of quality of life of patients undergoing treatment is of growing interest.
The following article will discuss the concept and theoretical frame-work of a study designed to evaluate quality of life in adult patients with acute myeloid leukemia undergoing chemotherapy.
Preliminary results show the psychooncological relevance of the study for the clinician.
在肿瘤学领域，生活质量已成为评估临床试验中治疗效果的重要标准。到目前为止，成年急性白血病患者的生活质量评估可能尚未得到重视，这可能是由于疾病预后不良和病程急性所致。化疗的进展显著延长了急性髓系白血病患者的生存期，并且可能治愈一部分患者。因此，对接受治疗患者的生活质量评估越来越受到关注。
以下文章将讨论一项旨在评估接受化疗的成年急性髓系白血病患者生活质量的研究的概念和理论框架。
初步结果显示了该研究对临床医生的心理肿瘤学相关性。
